Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 441

1.

Gastric bypass surgery in the treatment of gastro-oesophageal reflux symptoms.

Holmberg D, Santoni G, Xie S, Lagergren J.

Aliment Pharmacol Ther. 2019 Jun 4. doi: 10.1111/apt.15274. [Epub ahead of print]

PMID:
31165515
2.

Reply to: Helicobacter pylori eradication treatment and the risk of gastric adenocarcinoma in a western population.

Doorakkers E, Lagergren J, Engstrand L, Brusselaers N.

Gut. 2019 May 21. pii: gutjnl-2019-319000. doi: 10.1136/gutjnl-2019-319000. [Epub ahead of print] No abstract available.

PMID:
31113849
3.

Prediabetes and diabetes in relation to risk of gastric adenocarcinoma.

Zheng J, Rutegård M, Santoni G, Wallner B, Johansson I, Sund M, Xie SH, Lagergren J.

Br J Cancer. 2019 Jun;120(12):1147-1152. doi: 10.1038/s41416-019-0470-1. Epub 2019 May 7.

PMID:
31061455
4.

Effects of Obesity Surgery on Overall and Disease-Specific Mortality in a 5-Country Population-Based Study.

Kauppila JH, Tao W, Santoni G, von Euler-Chelpin M, Lynge E, Tryggvadóttir L, Ness-Jensen E, Romundstad P, Pukkala E, Lagergren J.

Gastroenterology. 2019 Jul;157(1):119-127.e1. doi: 10.1053/j.gastro.2019.03.048. Epub 2019 Mar 30.

PMID:
30940524
5.
6.

Annual hospital volume of surgery for gastrointestinal cancer in relation to prognosis.

Gottlieb-Vedi E, Mattsson F, Lagergren P, Lagergren J.

Eur J Surg Oncol. 2019 Mar 15. pii: S0748-7983(19)30341-5. doi: 10.1016/j.ejso.2019.03.016. [Epub ahead of print]

PMID:
30904243
7.

Preoperative esophageal stenting and short-term outcomes of surgery for esophageal cancer in a population-based study from Finland and Sweden.

Helminen O, Kauppila JH, Kytö V, Gunn J, Lagergren J, Sihvo E.

Dis Esophagus. 2019 Mar 11. pii: doz005. doi: 10.1093/dote/doz005. [Epub ahead of print]

PMID:
30855081
8.

Long-term Survival in Esophageal Cancer After Minimally Invasive Compared to Open Esophagectomy: A Systematic Review and Meta-analysis.

Gottlieb-Vedi E, Kauppila JH, Malietzis G, Nilsson M, Markar SR, Lagergren J.

Ann Surg. 2019 Feb 21. doi: 10.1097/SLA.0000000000003252. [Epub ahead of print]

PMID:
30817355
9.

No Association Between Vitamin D Status and Risk of Barrett's Esophagus or Esophageal Adenocarcinoma: A Mendelian Randomization Study.

Dong J, Gharahkhani P, Chow WH, Gammon MD, Liu G, Caldas C, Wu AH, Ye W, Onstad L, Anderson LA, Bernstein L, Pharoah PD, Risch HA, Corley DA, Fitzgerald RC; Stomach and Esophageal Cancer Study Consortium, Iyer PG, Reid BJ, Lagergren J, Shaheen NJ, Vaughan TL, MacGregor S, Love S, Palles C, Tomlinson I, Gockel I, May A, Gerges C, Anders M, Böhmer AC, Becker J, Kreuser N, Thieme R, Noder T, Venerito M, Veits L, Schmidt T, Schmidt C, Izbicki JR, Hölscher AH, Lang H, Lorenz D, Schumacher B, Mayershofer R, Vashist Y, Ott K, Vieth M, Weismüller J, Nöthen MM, Moebus S, Knapp M, Peters WHM, Neuhaus H, Rösch T, Ell C, Jankowski J, Schumacher J, Neale RE, Whiteman DC, Thrift AP.

Clin Gastroenterol Hepatol. 2019 Feb 1. pii: S1542-3565(19)30088-6. doi: 10.1016/j.cgh.2019.01.041. [Epub ahead of print]

PMID:
30716477
10.

Cohort profile: the Swedish Prescribed Drugs and Health Cohort (SPREDH).

Xie SH, Santoni G, Mattsson F, Ness-Jensen E, Lagergren J.

BMJ Open. 2019 Jan 28;9(1):e023155. doi: 10.1136/bmjopen-2018-023155.

11.

Menopausal hormone therapy and biliary tract cancer: a population-based matched cohort study in Sweden.

Kilander C, Lagergren J, Konings P, Sadr-Azodi O, Brusselaers N.

Acta Oncol. 2019 Mar;58(3):290-295. doi: 10.1080/0284186X.2018.1549367. Epub 2019 Jan 18.

PMID:
30656997
12.

Prediction of individuals at high absolute risk of esophageal squamous cell carcinoma.

Wang QL, Lagergren J, Xie SH.

Gastrointest Endosc. 2019 Apr;89(4):726-732.e2. doi: 10.1016/j.gie.2018.10.025. Epub 2018 Oct 25.

PMID:
30616974
13.

A population-based cohort study examining the risk of abdominal cancer after endovascular abdominal aortic aneurysm repair.

Markar SR, Vidal-Diez A, Sounderajah V, Mackenzie H, Hanna GB, Thompson M, Holt P, Lagergren J, Karthikesalingam A.

J Vasc Surg. 2019 Jun;69(6):1776-1785.e2. doi: 10.1016/j.jvs.2018.09.058. Epub 2018 Dec 21.

PMID:
30583890
14.

Risk factors for oesophageal cancer.

Xie SH, Lagergren J.

Best Pract Res Clin Gastroenterol. 2018 Oct - Dec;36-37:3-8. doi: 10.1016/j.bpg.2018.11.008. Epub 2018 Nov 22. Review.

PMID:
30551854
15.

Reintervention After Antireflux Surgery for Gastroesophageal Reflux Disease in England.

Markar SR, Arhi C, Wiggins T, Vidal-Diez A, Karthikesalingam A, Darzi A, Lagergren J, Hanna GB.

Ann Surg. 2018 Nov 29. doi: 10.1097/SLA.0000000000003131. [Epub ahead of print]

PMID:
30499807
16.

Outcomes of nutritional jejunostomy in the curative treatment of esophageal cancer.

Klevebro F, Johar A, Lagergren J, Lagergren P.

Dis Esophagus. 2018 Nov 28. doi: 10.1093/dote/doy113. [Epub ahead of print]

PMID:
30496419
17.

A seven-Gene Signature assay improves prognostic risk stratification of perioperative chemotherapy treated gastroesophageal cancer patients from the MAGIC trial.

Smyth EC, Nyamundanda G, Cunningham D, Fontana E, Ragulan C, Tan IB, Lin SJ, Wotherspoon A, Nankivell M, Fassan M, Lampis A, Hahne JC, Davies AR, Lagergren J, Gossage JA, Maisey N, Green M, Zylstra JL, Allum WH, Langley RE, Tan P, Valeri N, Sadanandam A.

Ann Oncol. 2018 Dec 1;29(12):2356-2362. doi: 10.1093/annonc/mdy407.

18.

Clinical prediction model for tumor progression in Barrett's esophagus.

Holmberg D, Ness-Jensen E, Mattsson F, Lagergren J.

Surg Endosc. 2018 Nov 19. doi: 10.1007/s00464-018-6590-5. [Epub ahead of print]

PMID:
30456503
19.

Risk of Esophageal Adenocarcinoma After Antireflux Surgery in Patients With Gastroesophageal Reflux Disease in the Nordic Countries.

Maret-Ouda J, Wahlin K, Artama M, Brusselaers N, Färkkilä M, Lynge E, Mattsson F, Pukkala E, Romundstad P, Tryggvadóttir L, von Euler-Chelpin M, Lagergren J.

JAMA Oncol. 2018 Nov 1;4(11):1576-1582. doi: 10.1001/jamaoncol.2018.3054.

PMID:
30422249
20.

Acute upper gastrointestinal bleeding.

Sverdén E, Markar SR, Agreus L, Lagergren J.

BMJ. 2018 Oct 25;363:k4023. doi: 10.1136/bmj.k4023. No abstract available.

PMID:
30361444
21.

Surgeon Volume and Surgeon Age in Relation to Proficiency Gain Curves for Prognosis Following Surgery for Esophageal Cancer.

Gottlieb-Vedi E, Mackenzie H, van Workum F, Rosman C, Lagergren P, Markar S, Lagergren J.

Ann Surg Oncol. 2019 Feb;26(2):497-505. doi: 10.1245/s10434-018-6869-8. Epub 2018 Oct 15.

22.

Implant Based Breast Reconstruction With Acellular Dermal Matrix: Safety Data From an Open-label, Multicenter, Randomized, Controlled Trial in the Setting of Breast Cancer Treatment.

Lohmander F, Lagergren J, Roy PG, Johansson H, Brandberg Y, Eriksen C, Frisell J.

Ann Surg. 2019 May;269(5):836-841. doi: 10.1097/SLA.0000000000003054.

PMID:
30308615
23.

ASO Author Reflections: Survival Trends in Gastric Adenocarcinoma.

Asplund J, Lagergren J.

Ann Surg Oncol. 2018 Dec;25(Suppl 3):723-724. doi: 10.1245/s10434-018-6844-4. Epub 2018 Oct 8. No abstract available.

24.

Information on Genetic Variants Does Not Increase Identification of Individuals at Risk of Esophageal Adenocarcinoma Compared to Clinical Risk Factors.

Kunzmann AT, Cañadas Garre M, Thrift AP, McMenamin ÚC, Johnston BT, Cardwell CR, Anderson LA, Spence AD, Lagergren J, Xie SH, Smyth LJ, McKnight AJ, Coleman HG.

Gastroenterology. 2019 Jan;156(1):43-45. doi: 10.1053/j.gastro.2018.09.038. Epub 2018 Sep 19.

PMID:
30243622
25.

Sex differences in the prognosis after surgery for esophageal squamous cell carcinoma and adenocarcinoma.

Kauppila JH, Wahlin K, Lagergren P, Lagergren J.

Int J Cancer. 2019 Mar 15;144(6):1284-1291. doi: 10.1002/ijc.31840. Epub 2018 Oct 31.

PMID:
30168595
26.

Population-based cohort study of diabetes mellitus and mortality in gastric adenocarcinoma.

Zheng J, Xie SH, Santoni G, Lagergren J.

Br J Surg. 2018 Dec;105(13):1799-1806. doi: 10.1002/bjs.10930. Epub 2018 Jul 27.

PMID:
30051463
27.

The Influence of Antireflux Surgery on Esophageal Cancer Risk in England: National Population-based Cohort Study.

Markar SR, Arhi C, Leusink A, Vidal-Diez A, Karthikesalingam A, Darzi A, Lagergren J, Hanna GB.

Ann Surg. 2018 Nov;268(5):861-867. doi: 10.1097/SLA.0000000000002890.

PMID:
30048317
28.

Lymph node regression and survival following neoadjuvant chemotherapy in oesophageal adenocarcinoma.

Davies AR, Myoteri D, Zylstra J, Baker CR, Wulaningsih W, Van Hemelrijck M, Maisey N, Allum WH, Smyth E, Gossage JA, Lagergren J, Cunningham D, Green M; Guy's and St Thomas' Oesophago-Gastric Research Group and PROGRESS Study Group.

Br J Surg. 2018 Nov;105(12):1639-1649. doi: 10.1002/bjs.10900. Epub 2018 Jul 26.

PMID:
30047556
29.

The population-based incidence and mortality of biliary tract cancer in Sweden.

Kilander C, Lagergren J, Ljung R, Sadr-Azodi O.

Cancer Epidemiol. 2018 Oct;56:14-20. doi: 10.1016/j.canep.2018.06.004. Epub 2018 Jul 17.

PMID:
30025250
30.

Obesity surgery and risk of cancer.

Mackenzie H, Markar SR, Askari A, Faiz O, Hull M, Purkayastha S, Møller H, Lagergren J.

Br J Surg. 2018 Nov;105(12):1650-1657. doi: 10.1002/bjs.10914. Epub 2018 Jul 13.

PMID:
30003539
31.

Survival Trends in Gastric Adenocarcinoma: A Population-Based Study in Sweden.

Asplund J, Kauppila JH, Mattsson F, Lagergren J.

Ann Surg Oncol. 2018 Sep;25(9):2693-2702. doi: 10.1245/s10434-018-6627-y. Epub 2018 Jul 9.

32.
33.

Global time trends in the incidence of esophageal squamous cell carcinoma.

Wang QL, Xie SH, Wahlin K, Lagergren J.

Clin Epidemiol. 2018 Jun 19;10:717-728. doi: 10.2147/CLEP.S166078. eCollection 2018.

34.

Outcome of Patients Treated Within and Outside a Randomized Clinical Trial on Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: Extrapolation of a Randomized Clinical Trial (CROSS).

Toxopeus E, van der Schaaf M, van Lanschot J, Lagergren J, Lagergren P, van der Gaast A, Wijnhoven B.

Ann Surg Oncol. 2018 Aug;25(8):2441-2448. doi: 10.1245/s10434-018-6554-y. Epub 2018 Jun 12.

35.

Smoking Cessation and Risk of Esophageal Cancer by Histological Type: Systematic Review and Meta-analysis.

Wang QL, Xie SH, Li WT, Lagergren J.

J Natl Cancer Inst. 2017 Dec 1;109(12). doi: 10.1093/jnci/djx115.

PMID:
29933436
36.

Spatial maps of prostate cancer transcriptomes reveal an unexplored landscape of heterogeneity.

Berglund E, Maaskola J, Schultz N, Friedrich S, Marklund M, Bergenstråhle J, Tarish F, Tanoglidi A, Vickovic S, Larsson L, Salmén F, Ogris C, Wallenborg K, Lagergren J, Ståhl P, Sonnhammer E, Helleday T, Lundeberg J.

Nat Commun. 2018 Jun 20;9(1):2419. doi: 10.1038/s41467-018-04724-5.

37.

Different menopausal hormone regimens and risk of breast cancer.

Brusselaers N, Tamimi RM, Konings P, Rosner B, Adami HO, Lagergren J.

Ann Oncol. 2018 Aug 1;29(8):1771-1776. doi: 10.1093/annonc/mdy212.

PMID:
29917061
38.

Response "Surgeon Age in Relation to Prognosis After Esophageal Cancer Resection".

Markar SR, Lagergren J.

Ann Surg. 2019 Jan;269(1):e7. doi: 10.1097/SLA.0000000000002841. No abstract available.

PMID:
29864096
39.

Selektiv nivåstrukturering av svensk kirurgi behövs.

Andersson R, Hellman P, Johansson J, Lagergren J, Martling A, Naredi P, Nilsson M, Sund M.

Lakartidningen. 2018 May 25;115. pii: E76E. Swedish. No abstract available.

40.

Assessment of a Noninvasive Exhaled Breath Test for the Diagnosis of Oesophagogastric Cancer.

Markar SR, Wiggins T, Antonowicz S, Chin ST, Romano A, Nikolic K, Evans B, Cunningham D, Mughal M, Lagergren J, Hanna GB.

JAMA Oncol. 2018 Jul 1;4(7):970-976. doi: 10.1001/jamaoncol.2018.0991.

41.

Social group disparities in the incidence and prognosis of oesophageal cancer.

Xie SH, Lagergren J.

United European Gastroenterol J. 2018 Apr;6(3):343-348. doi: 10.1177/2050640617751254. Epub 2018 Jan 10. Review.

42.

Assessing the feasibility of targeted screening for esophageal adenocarcinoma based on individual risk assessment in a population-based cohort study in Norway (The HUNT Study).

Xie SH, Ness-Jensen E, Medefelt N, Lagergren J.

Am J Gastroenterol. 2018 Jun;113(6):829-835. doi: 10.1038/s41395-018-0069-9. Epub 2018 May 11.

PMID:
29748563
43.

Prognosis of oesophageal adenocarcinoma and squamous cell carcinoma following surgery and no surgery in a nationwide Swedish cohort study.

Kauppila JH, Mattsson F, Brusselaers N, Lagergren J.

BMJ Open. 2018 May 10;8(5):e021495. doi: 10.1136/bmjopen-2018-021495.

44.

PPI use and oesophageal cancer: What if the results are true?

Brusselaers N, Engstrand L, Lagergren J.

Cancer Epidemiol. 2018 Jun;54:139-140. doi: 10.1016/j.canep.2018.04.004. Epub 2018 Apr 9. No abstract available.

PMID:
29650437
45.

Forecasting and Uncertainty Quantification Using a Hybrid of Mechanistic and Non-mechanistic Models for an Age-Structured Population Model.

Lagergren J, Reeder A, Hamilton F, Smith RC, Flores KB.

Bull Math Biol. 2018 Jun;80(6):1578-1595. doi: 10.1007/s11538-018-0421-7. Epub 2018 Apr 2.

PMID:
29611108
46.

Updated incidence trends in cardia and non-cardia gastric adenocarcinoma in Sweden.

Lagergren F, Xie SH, Mattsson F, Lagergren J.

Acta Oncol. 2018 Sep;57(9):1173-1178. doi: 10.1080/0284186X.2018.1457797. Epub 2018 Mar 30.

PMID:
29600886
47.

Model for Identifying Individuals at Risk for Esophageal Adenocarcinoma.

Kunzmann AT, Thrift AP, Cardwell CR, Lagergren J, Xie S, Johnston BT, Anderson LA, Busby J, McMenamin ÚC, Spence AD, Coleman HG.

Clin Gastroenterol Hepatol. 2018 Aug;16(8):1229-1236.e4. doi: 10.1016/j.cgh.2018.03.014. Epub 2018 Mar 17.

PMID:
29559360
48.

Interactions Between Genetic Variants and Environmental Factors Affect Risk of Esophageal Adenocarcinoma and Barrett's Esophagus.

Dong J, Levine DM, Buas MF, Zhang R, Onstad L, Fitzgerald RC; Stomach and Oesophageal Cancer Study (SOCS) Consortium, Corley DA, Shaheen NJ, Lagergren J, Hardie LJ, Reid BJ, Iyer PG, Risch HA, Caldas C, Caldas I, Pharoah PD, Liu G, Gammon MD, Chow WH, Bernstein L, Bird NC, Ye W, Wu AH, Anderson LA, MacGregor S, Whiteman DC, Vaughan TL, Thrift AP.

Clin Gastroenterol Hepatol. 2018 Oct;16(10):1598-1606.e4. doi: 10.1016/j.cgh.2018.03.007. Epub 2018 Mar 15.

49.

University hospital status and surgeon volume and risk of reoperation following surgery for esophageal cancer.

Kauppila JH, Wahlin K, Lagergren P, Lagergren J.

Eur J Surg Oncol. 2018 May;44(5):632-637. doi: 10.1016/j.ejso.2018.02.212. Epub 2018 Mar 2.

PMID:
29548804
50.

Evolutionary history of metastatic breast cancer reveals minimal seeding from axillary lymph nodes.

Ullah I, Karthik GM, Alkodsi A, Kjällquist U, Stålhammar G, Lövrot J, Martinez NF, Lagergren J, Hautaniemi S, Hartman J, Bergh J.

J Clin Invest. 2018 Apr 2;128(4):1355-1370. doi: 10.1172/JCI96149. Epub 2018 Feb 26.

Supplemental Content

Loading ...
Support Center